Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma

Abstract

Reactive astrocytes evolve after brain injury, inflammatory and degenerative diseases, whereby they undergo transcriptomic re-programming. In malignant brain tumors, their function and crosstalk to other components of the environment is poorly understood. Here we report a distinct transcriptional phenotype of reactive astrocytes from glioblastoma linked to JAK/STAT pathway activation. Subsequently, we investigate the origin of astrocytic transformation by a microglia loss-of-function model in a human organotypic slice model with injected tumor cells. RNA-seq based gene expression analysis of astrocytes reveals a distinct astrocytic phenotype caused by the coexistence of microglia and astrocytes in the tumor environment, which leads to a large release of anti-inflammatory cytokines such as TGFβ, IL10 and G-CSF. Inhibition of the JAK/STAT pathway shifts the balance of pro- and anti-inflammatory cytokines towards a pro-inflammatory environment. The complex interaction of astrocytes and microglia cells promotes an immunosuppressive environment, suggesting that tumor-associated astrocytes contribute to anti-inflammatory responses.

References 50

1. 1.

   Crocetti E, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur. J. Cancer. 2012;48:1532-1542.

   Not in our library10.1016/j.ejca.2011.12.013

2. 2.

   Ostrom QT, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro. Oncol. 2014;16:896-913.

   Not in our library10.1093/neuonc/nou087

3. 3.

   Ostrom QT, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro. Oncol. 2014;16(Suppl 4):iv1-iv63.

   Not in our library10.1093/neuonc/nou223

4. 4.

   Gilbert MR, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N. Engl. J. Med. 2014;370:699-708.

   Not in our library10.1056/nejmoa1308573

5. 5.

   Chinot OL, Wick W, Cloughesy T. Bevacizumab for newly diagnosed glioblastoma. N. Engl. J. Med. 2014;370:2049.

   Not in our library10.1056/nejmoa1308345

6. 6.

   Taal W, et al. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. Lancet Oncol. 2014;15:943-953.

   Not in our library10.1016/s1470-2045(14)70314-6

7. 7.

   Vredenburgh JJ, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J. Clin. Oncol. 2007;25:4722-4729.

   Not in our library10.1200/jco.2007.12.2440

8. 8.

   Friedman HS, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J. Clin. Oncol. 2009;27:4733-4740.

   Not in our library10.1200/jco.2008.19.8721

9. 9.

   Van Meir EG, et al. Exciting new advances in neuro-oncology. CA Cancer J. Clin. 2010;60:166-193.

   Not in our library10.3322/caac.20069

10. 10.

    Whiteside T L. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904-5912.

    Not in our library10.1038/onc.2008.271

11. 11.

    Darmanis S, et al. Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 2017;21:1399-1410.

    Not in our library10.1016/j.celrep.2017.10.030

12. 12.

    Zhang Y, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 2014;34:11929-11947.

    Not in our library10.1523/jneurosci.1860-14.2014

13. 13.

    Zhang Y, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37-53.

    Not in our library10.1016/j.neuron.2015.11.013

14. 14.

    Matyash V, Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 2010;63:2-10.

    Not in our library10.1016/j.brainresrev.2009.12.001

15. 15.

    Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46:957-967.

    Not in our library10.1016/j.immuni.2017.06.006

16. 16.

    Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481-487.

    Not in our library10.1038/nature21029

17. 17.

    Zamanian JL, et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012;32:6391-6410.

    Not in our library10.1523/jneurosci.6221-11.2012

18. 18.

    Priego Neibla, Zhu Lucía, Monteiro Cátia, Mulders Manon, Wasilewski David, Bindeman Wendy, Doglio Laura, Martínez Liliana, Martínez-Saez Elena, Ramón y Cajal Santiago, Megías Diego, Hernández-Encinas Elena, Blanco-Aparicio Carmen, Martínez Lola, Zarzuela Eduardo, Muñoz Javier, Fustero-Torre Coral, Piñeiro-Yáñez Elena, Hernández-Laín Aurelio, Bertero Luca, Poli Valeria, Sanchez-Martinez Melchor, Menendez Javier A., Soffietti Riccardo, Bosch-Barrera Joaquim, Valiente Manuel. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nature Medicine. 2018;24(7):1024-1035.

    Not in our library10.1038/s41591-018-0044-4

19. 19.

    Yun Seung Pil, Kam Tae-In, Panicker Nikhil, Kim SangMin, Oh Yumin, Park Jong-Sung, Kwon Seung-Hwan, Park Yong Joo, Karuppagounder Senthilkumar S., Park Hyejin, Kim Sangjune, Oh Nayeon, Kim Nayoung Alice, Lee Saebom, Brahmachari Saurav, Mao Xiaobo, Lee Jun Hee, Kumar Manoj, An Daniel, Kang Sung-Ung, Lee Yunjong, Lee Kang Choon, Na Dong Hee, Kim Donghoon, Lee Sang Hun, Roschke Viktor V., Liddelow Shane A., Mari Zoltan, Barres Ben A., Dawson Valina L., Lee Seulki, Dawson Ted M., Ko Han Seok. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease. Nature Medicine. 2018;24(7):931-938.

    Not in our library10.1038/s41591-018-0051-5

20. 20.

    Zschaler, J., Schlorke, D. & Arnhold, J. Differences in innate immune response between man and mouse. Crit. Rev. Immunol. (2014). 10.1615/critrevimmunol.2014011600

    Not in our library

21. 21.

    Martinez F. O., Gordon S., Locati M., Mantovani A. Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression. The Journal of Immunology. 2006;177(10):7303-7311.

    Not in our library10.4049/jimmunol.177.10.7303

22. 22.

    Hellwig, S. et al. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures. Sci. Rep. (2015). 10.1038/srep14624

    Not in our library10.1038/srep14624

23. 23.

    Keskin Derin B., Anandappa Annabelle J., Sun Jing, Tirosh Itay, Mathewson Nathan D., Li Shuqiang, Oliveira Giacomo, Giobbie-Hurder Anita, Felt Kristen, Gjini Evisa, Shukla Sachet A., Hu Zhuting, Li Letitia, Le Phuong M., Allesøe Rosa L., Richman Alyssa R., Kowalczyk Monika S., Abdelrahman Sara, Geduldig Jack E., Charbonneau Sarah, Pelton Kristine, Iorgulescu J. Bryan, Elagina Liudmila, Zhang Wandi, Olive Oriol, McCluskey Christine, Olsen Lars R., Stevens Jonathan, Lane William J., Salazar Andres M., Daley Heather, Wen Patrick Y., Chiocca E. Antonio, Harden Maegan, Lennon Niall J., Gabriel Stacey, Getz Gad, Lander Eric S., Regev Aviv, Ritz Jerome, Neuberg Donna, Rodig Scott J., Ligon Keith L., Suvà Mario L., Wucherpfennig Kai W., Hacohen Nir, Fritsch Edward F., Livak Kenneth J., Ott Patrick A., Wu Catherine J., Reardon David A. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2018;565(7738):234-239.

    Not in our library10.1038/s41586-018-0792-9

24. 24.

    Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 2016;173:649-665.

    Not in our library10.1111/bph.13139

25. 25.

    Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro. Oncol. 2012;14:958-978.

    Not in our library10.1093/neuonc/nos116

26. 26.
    Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1 · 2015

    No notice
27. 27.

    Platten Michael. T cells engineered to home in on brain cancer. Nature. 2018;561(7723):319-320.

    Not in our library10.1038/d41586-018-05883-7

28. 28.

    Cahoy JD, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008;28:264-278.

    Not in our library10.1523/jneurosci.4178-07.2008

29. 29.

    Clarke LE, et al. Normal aging induces A1-like astrocyte reactivity. Proc. Natl Acad. Sci. 2018;115:E1896-E1905.

    Not in our library10.1073/pnas.1800165115

30. 30.

    Sloan SA, et al. Human astrocyte maturation captured in 3D cerebral cortical spheroids derived from pluripotent stem cells. Neuron. 2017;95:779-790.e6.

    Not in our library10.1016/j.neuron.2017.07.035

31. 31.

    He F, et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 2005;8:616-625.

    Not in our library10.1038/nn1440

32. 32.

    Anderson MA, et al. Astrocyte scar formation AIDS central nervous system axon regeneration. Nature. 2016;532:195-200.

    Not in our library10.1038/nature17623

33. 33.

    Ding X, et al. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J. Immunol. 2015;194:4251-4264.

    Not in our library10.4049/jimmunol.1303321

34. 34.

    Garcia-Diaz A, et al. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 2017;19:1189-1201.

    Not in our library10.1016/j.celrep.2017.04.031

35. 35.

    Pittet CL, Newcombe J, Antel JP, Arbour N. The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells. Glia. 2011;59:841-856.

    Not in our library10.1002/glia.21158

36. 36.

    Nduom EK, Weller M, Heimberger AB. Immunosuppressive mechanisms in glioblastoma. Neuro. Oncol. 2015;17:vii9-vii14.

    Not in our library10.1093/neuonc/nov151

37. 37.

    Platten, M., Ochs, K., Lemke, D., Opitz, C. & Wick, W. Microenvironmental clues for glioma immunotherapy. Curr. Neurol. Neurosci. Rep. 14, 440 (2014).

    Not in our library10.1007/s11910-014-0440-1

38. 38.

    Li P, Gallo V, Huntsman M, Mangin J-M, Raymond M. Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the janus kinase/signal transducer and activator of transcription pathway. J. Neurosci. 2011;31:17864-17871.

    Not in our library10.1523/jneurosci.3179-11.2011

39. 39.

    Rajappa P, et al. Malignant astrocytic tumor progression potentiated by JAK-mediated recruitment of myeloid cells. Clin. Cancer Res. 2017;23:3109-3119.

    Not in our library10.1158/1078-0432.ccr-16-1508

40. 40.

    Heiland Dieter Henrik, Gaebelein Annette, Börries Melanie, Wörner Jakob, Pompe Nils, Franco Pamela, Heynckes Sabrina, Bartholomae Mark, hAilín Darren Ó., Carro Maria Stella, Prinz Marco, Weber Stefan, Mader Irina, Delev Daniel, Schnell Oliver. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme. Molecular Cancer Research. 2018;16(4):655-668.

    Not in our library10.1158/1541-7786.mcr-17-0680

Cited by papers we hold 14

• Invasion and metastasis in cancer: molecular insights and therapeutic targets · 2025
  No notice
• Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment · 2023
  No notice
• Spatial cellular architecture predicts prognosis in glioblastoma · 2023
  No notice
• LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma · 2022
  Not checked
• The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications · 2022
  Not checked
• T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 · 2022
  No notice
• The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis · 2022
  No notice
• Stroke subtype-dependent synapse elimination by reactive gliosis in mice · 2021
  Corrected
• Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes · 2021
  No notice
• The Interplay between Glioblastoma and Its Microenvironment · 2021
  No notice
• Macrophages and microglia: the cerberus of glioblastoma · 2021
  No notice
• Neuropathobiology of COVID-19: The Role for Glia · 2020
  No notice
• Molecular and cellular mechanisms underlying brain metastasis of breast cancer · 2020
  No notice
• Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.